| Identification | Back Directory | [Name]
2-Propenamide, N-[[4-(4-acetyl-1-piperazinyl)phenyl]methyl]-N-[2-[4-[(4-cyanophenyl)methyl]-1-piperazinyl]-2-oxo-1-(phenylmethyl)ethyl]-3-[4-(1,1-dimethylethyl)phenyl]-, (2E)- | [CAS]
1839508-99-4 | [Synonyms]
2-Propenamide, N-[[4-(4-acetyl-1-piperazinyl)phenyl]methyl]-N-[2-[4-[(4-cyanophenyl)methyl]-1-piperazinyl]-2-oxo-1-(phenylmethyl)ethyl]-3-[4-(1,1-dimethylethyl)phenyl]-, (2E)- | [Molecular Formula]
C47H54N6O3 | [MOL File]
1839508-99-4.mol | [Molecular Weight]
750.97 |
| Hazard Information | Back Directory | [Uses]
(Rac)-ACT-451840 is an isomer of ACT-451840 that exhibits significant antimalarial effects. (Rac)-ACT-451840 exhibits significant antimalarial activity against P. berghei-infected mice at a dose of 20 mg/kg (ED90=13 mg/kg), and has an inhibitory effect at a dose of 300 mg/kg. The ED90 of (Rac)-ACT-451840 in the P. falciparum humanized immunodeficient mouse model is 3.7 mg/kg. (Rac)-ACT-451840 is similar to artemisinin, with a rapid onset of action but requires repeated high doses. | [References]
[1] Discovery and characterization of ACT‐451840: an antimalarial drug with a novel mechanism of action |
|
|